Cumulus Neuroscience
PrivateLast Round
VC Round
Jul 8, 2025
Est. Valuation
$7.65M
Total Funding Raised
$18.86M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cumulus Neuroscience is a health technology company that provides an AI-powered digital biomarker platform with a wearable EEG headset and tablet-based assessments to accelerate clinical trials for central nervous system therapies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical Devices, Healthcare Analytics, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cumulus Neuroscience Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Cumulus Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 8, 2025 | ||||
| Grant | Jul 11, 2024 | ||||
| Early Funding | Jul 8, 2024 | ||||
| Grant | Mar 20, 2024 | ||||
| Series A | May 4, 2021 | ||||
VC Round | Jul 13, 2020 |
Cumulus Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | Early Funding, VC Round |
| Par Equity | VC Round |
| SV Health Investors | Seed, Series A |
| Whiterock Finance | Early Funding |
| British Business Bank | Series A, Early Funding |
| Innovate UK | Grant |
| Clarendon Fund Managers | Early Funding, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 49% MoM.
- Nov 9, 2025
Monthly visitors increased 43% MoM.
Cumulus Neuroscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cumulus Neuroscience's valuation, stock price, and market status.